1. Cao, J., Wu, L., Zhang, S. M., Lu, M., & Cheung, W. K. (2016). An easy and efficient inducible CRISPR/Cas9 platform with improved specificity for multiple gene targeting. Nucleic Acids Research, 44(19), e149.
2. Kawabata, K., Ujikawa, M., & Egawa, T. (1996). A cell-autonomous requirement for CXCR4 in long-term lymphoid and myeloid reconstitution. Proceedings of the National Academy of Sciences of the United States of America, 96(10), 5663–7.
3. Liang, Y., Votaw, G., & Williams, S. (2005). Silencing of CXCR4 blocks breast cancer metastasis. Cancer Research, 65(3), 967–71.
4. Xu, C., Zhao, & Chen, Y. (2015). CXCR4 in breast cancer: oncogenic role and therapeutic targeting. Drug Design Development and Therapy, 9, 4953–64.
5. Hayasaka, K., Yoshimura, D., Nakayama, H., Shioda, E. E., & Miya- saka, T. (2015). The HIV-1 Gp120/CXCR4 axis promotes CCR7 ligand-dependent CD4 T cell migration: CCR7 homo- and CCR7/CXCR4 hetero-oligomer formation as a possible mechanism for up-regulation of functional CCR7. PLoS ONE, 10(2), e0117454.